Stephen Hoffman
2019 - Aadi Bioscience
In 2019, Stephen Hoffman earned a total compensation of $2.1M as Former Chief Executive Officer at Aadi Bioscience, a 45% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,160,363 |
|---|---|
| Salary | $393,506 |
| Other | $534,832 |
| Total | $2,088,701 |
Hoffman received $1.2M in option awards, accounting for 56% of the total pay in 2019.
Hoffman also received $393.5K in salary and $534.8K in other compensation.
Rankings
In 2019, Stephen Hoffman's compensation ranked 5,706th out of 13,971 executives tracked by ExecPay. In other words, Hoffman earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,706 out of 13,971 | 59th |
Division Manufacturing | 2,135 out of 5,695 | 63rd |
Major group Chemicals And Allied Products | 767 out of 2,194 | 65th |
Industry group Drugs | 644 out of 1,880 | 66th |
Industry Pharmaceutical Preparations | 471 out of 1,392 | 66th |
Source: SEC filing on April 27, 2020.
Hoffman's colleagues
We found four more compensation records of executives who worked with Stephen Hoffman at Aadi Bioscience in 2019.
News
BODY & MIND CEO Michael Mills' 2022 pay slips 4% to $403K
February 10, 2023
BODY & MIND COO Stephen Hoffman's 2021 pay rises 2% to $462K
February 11, 2022
BODY & MIND COO Stephen Hoffman's 2020 pay jumps 106% to $451K
December 31, 2020
Aadi Bioscience CEO Stephen Hoffman's 2019 pay jumps 45% to $2.1M
April 27, 2020
BODY & MIND Director, and President of NMG Robert Hasman's 2019 pay rises 18% to $441K
December 10, 2019
Aadi Bioscience CEO Stephen Hoffman's 2018 pay falls 30% to $1.4M
April 30, 2019